The chamber of secretome in Mycobacterium tuberculosis as a potential therapeutic target.
Manish DwivediKriti BajpaiPublished in: Biotechnology & genetic engineering reviews (2022)
Mycobacterium tuberculosis (MTB) causes one of the ancient diseases, Tuberculosis, affects people around the globe and its severity can be understood by its classification as a second infectious disease after COVID-19 and the 13th leading cause of death according to a WHO report. Despite having advanced diagnostic approaches and therapeutic strategies, unfortunately, TB is still spreading across the population due to the emergence of drug-resistance MTB and Latent TB infection (LTBI). We are seeking for effective approaches to overcome these hindrances and efficient treatment for this perilous disease. Therefore, there is an urgent need to develop drugs based on operative targeting of the bacterial system that could result in both efficient treatment and lesser emergence of MDR-TB. One such promising target could be the secretory systems and especially the Type 7 secretory system (T7SS-ESX) of Mycobacterium tuberculosis, which is crucial for the secretion of effector proteins as well as in establishing host-pathogen interactions of the tubercle bacilli. The five paralogous ESX systems (ESX-1 to EXS-5) have been observed by in silico genome analysis of MTB, among which ESX-1 and ESX-5 are substantial for virulence and mediating host cellular inflammasome. The bacterium growth and virulence can be modulated by targeting the T7SS. In the present review, we demonstrate the current status of therapeutics against MTB and focus on the function and cruciality of T7SS along with other secretory systems as a promising therapeutic target against Tuberculosis.
Keyphrases
- mycobacterium tuberculosis
- pulmonary tuberculosis
- escherichia coli
- pseudomonas aeruginosa
- staphylococcus aureus
- current status
- coronavirus disease
- sars cov
- small molecule
- emergency department
- machine learning
- deep learning
- dendritic cells
- biofilm formation
- mental health
- antimicrobial resistance
- immune response
- genome wide
- climate change
- gene expression
- dna methylation
- adverse drug